U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088185) titled 'Pulmonary Outcomes on Patients With Lung Fibrosis' on June 17.
Brief Summary: The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.
Study Start Date: Dec. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Lung Fibrosis
Intervention:
OTHER: Routine medical care
Routine medical care
OTHER: Pulmonary rehabilitation
Pulmonary rehabilitation ( breathing exercises, posture drainage, additive techniques with postural drainage like vibration,shaking and percussion, active cycle of breathing t...